Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

839 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Report from the Rockefellar Foundation Sponsored International Workshop on reducing mortality and improving quality of life in long-term survivors of Hodgkin's disease: July 9-16, 2003, Bellagio, Italy.
Mauch P, Ng A, Aleman B, Carde P, Constine L, Diehl V, Dinshaw K, Gospodarowicz M, Hancock S, Hodgson D, Hoppe R, Liang R, Loeffler M, Specht L, Travis LB, Wirth A, Yahalom J. Mauch P, et al. Among authors: diehl v. Eur J Haematol Suppl. 2005 Jul;(66):68-76. doi: 10.1111/j.1600-0609.2005.00458.x. Eur J Haematol Suppl. 2005. PMID: 16007872
Meta-analysis of chemotherapy versus combined modality treatment trials in Hodgkin's disease. International Database on Hodgkin's Disease Overview Study Group.
Loeffler M, Brosteanu O, Hasenclever D, Sextro M, Assouline D, Bartolucci AA, Cassileth PA, Crowther D, Diehl V, Fisher RI, Hoppe RT, Jacobs P, Pater JL, Pavlovsky S, Thompson E, Wiernik P. Loeffler M, et al. Among authors: diehl v. J Clin Oncol. 1998 Mar;16(3):818-29. doi: 10.1200/JCO.1998.16.3.818. J Clin Oncol. 1998. PMID: 9508162
Second malignancy risk associated with treatment of Hodgkin's lymphoma: meta-analysis of the randomised trials.
Franklin J, Pluetschow A, Paus M, Specht L, Anselmo AP, Aviles A, Biti G, Bogatyreva T, Bonadonna G, Brillant C, Cavalieri E, Diehl V, Eghbali H, Fermé C, Henry-Amar M, Hoppe R, Howard S, Meyer R, Niedzwiecki D, Pavlovsky S, Radford J, Raemaekers J, Ryder D, Schiller P, Shakhtarina S, Valagussa P, Wilimas J, Yahalom J. Franklin J, et al. Among authors: diehl v. Ann Oncol. 2006 Dec;17(12):1749-60. doi: 10.1093/annonc/mdl302. Epub 2006 Sep 19. Ann Oncol. 2006. PMID: 16984979 Free article.
Hodgkin lymphoma: a curable disease: what comes next?
Diehl V, Klimm B, Re D. Diehl V, et al. Eur J Haematol Suppl. 2005 Jul;(66):6-13. doi: 10.1111/j.1600-0609.2005.00448.x. Eur J Haematol Suppl. 2005. PMID: 16007862 No abstract available.
Revised response criteria for malignant lymphoma.
Cheson BD, Pfistner B, Juweid ME, Gascoyne RD, Specht L, Horning SJ, Coiffier B, Fisher RI, Hagenbeek A, Zucca E, Rosen ST, Stroobants S, Lister TA, Hoppe RT, Dreyling M, Tobinai K, Vose JM, Connors JM, Federico M, Diehl V; International Harmonization Project on Lymphoma. Cheson BD, et al. Among authors: diehl v. J Clin Oncol. 2007 Feb 10;25(5):579-86. doi: 10.1200/JCO.2006.09.2403. Epub 2007 Jan 22. J Clin Oncol. 2007. PMID: 17242396
839 results